SCHEMBL14733339

SCHEMBL14733339

COc1ccc(N2CCN(c3ccc(C)c(N4CCN(C)CC4)n3)C2=O)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 7/20 0.45
ALDH1A1 P00352 6/20 0.41
CYP1A2 P05177 3/20 0.41
CYP2C19 P33261 2/20 0.41
CLK4 Q9HAZ1 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HPGD P15428 1/20 0.41
KDM4E B2RXH2 2/20 0.41
MAPT P10636 2/20 0.41
LMNA P02545 2/20 0.41
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
GAA P10253 1/20 0.40
TRPV4 Q9HBA0 1/20 0.40
USP2 O75604 2/20 0.39
CASP1 P29466 2/20 0.39
CASP7 P55210 2/20 0.39
HIF1A Q16665 2/20 0.39
HSD17B10 Q99714 2/20 0.39
CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2360469 0.89 HRH4 (0.45) HRH4ALDH1A1CYP1A2CYP2C19CLK4
SCHEMBL14733340 0.86 DRD2 (0.43) HRH4ALDH1A1MAPTKMT2AMEN1
SCHEMBL14733341 0.86 KMT2A (0.47) HRH4ALDH1A1CYP1A2MAPTKMT2A
SCHEMBL14733346 0.82 HRH4 (0.42) HRH4ALDH1A1CYP1A2CYP2C19CLK4
SCHEMBL2331617 0.79 HRH4 (0.44) HRH4ALDH1A1CYP1A2CYP2C19CLK4
SCHEMBL2333076 0.79 HRH4 (0.42) HRH4ALDH1A1SMN1; SMN2HPGDKDM4E
SCHEMBL2328041 0.78 HTR2A (0.44) HRH4ALDH1A1CYP1A2CYP2C19MAPT
SCHEMBL12445260 0.70 MAPT (0.45) HRH4ALDH1A1CYP1A2CYP2C19CLK4
SCHEMBL10556235 0.69 KMT2A (0.53) ALDH1A1SMN1; SMN2KDM4EMAPTLMNA
SCHEMBL12427204 0.68 NOX4 (0.49) MAPTKMT2AMEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130053372-A1 5-HT RECEPTOR MODULATORS CAMBRIDGE ENTERPRISE LIMITED 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130053372-A1 5-HT RECEPTOR MODULATORS HTR1B, HTR5A, HTR1A HRH4 350/4885ALDH1A1 987/4885CYP1A2 627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.